CHKA Antibody
-
货号:CSB-PA005353LA01HU
-
规格:¥440
-
促销:
-
图片:
-
Western Blot
Positive WB detected in: MCF-7 whole cell lysate
All lanes: CHKA antibody at 3µg/ml
Secondary
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 53, 51 kDa
Observed band size: 53 kDa -
Immunohistochemistry of paraffin-embedded human lung cancer using CSB-PA005353LA01HU at dilution of 1:100
-
Immunofluorescence staining of HepG2 cells with CSB-PA005353LA01HU at 1:100, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).
-
-
其他:
产品详情
-
产品名称:Rabbit anti-Homo sapiens (Human) CHKA Polyclonal antibody
-
Uniprot No.:P35790
-
基因名:CHKA
-
别名:CHKA antibody; CHK antibody; CKI antibody; Choline kinase alpha antibody; CK antibody; EC 2.7.1.32 antibody; CHETK-alpha antibody; Ethanolamine kinase antibody; EK antibody; EC 2.7.1.82 antibody
-
宿主:Rabbit
-
反应种属:Human
-
免疫原:Recombinant Human Choline kinase alpha protein (79-173AA)
-
免疫原种属:Homo sapiens (Human)
-
标记方式:Non-conjugated
本页面中的产品,CHKA Antibody (CSB-PA005353LA01HU),的标记方式是Non-conjugated。对于CHKA Antibody,我们还提供其他标记。见下表:
-
克隆类型:Polyclonal
-
抗体亚型:IgG
-
纯化方式:>95%, Protein G purified
-
浓度:It differs from different batches. Please contact us to confirm it.
-
保存缓冲液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 -
产品提供形式:Liquid
-
应用范围:ELISA, WB, IHC, IF
-
推荐稀释比:
Application Recommended Dilution WB 1:500-1:5000 IHC 1:20-1:200 IF 1:50-1:200 -
Protocols:
-
储存条件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
货期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
相关产品
靶点详情
-
功能:Has a key role in phospholipid biosynthesis and may contribute to tumor cell growth. Catalyzes the first step in phosphatidylcholine biosynthesis. Contributes to phosphatidylethanolamine biosynthesis. Phosphorylates choline and ethanolamine. Has higher activity with choline.
-
基因功能参考文献:
- miR-876-5p was able to significantly decrease the expression level of choline kinase alpha mRNA. PMID: 29568919
- There is no correlation between single CHKA rs7928739 polymorphism and the incidence of intrauterine fetal death. PMID: 28509322
- This study presents the detail the 2.35 A structure of choline kinase alpha in complex with inhibitor TCD-717. PMID: 29389115
- Results indicate that choline kinase alpha (CHKA) contributes to tumor progression and metastasis and may serve as a prognostic biomarker and potential therapeutic target in colorectal carcinoma (CRC). PMID: 27556502
- hCKalpha functions as an indispensable regulator that bridges PI4KIIIalpha and hepatitis C virus NS5A and potentiates NS5A-stimulated PI4KIIIalpha activity, which then facilitates the targeting of the ternary complex to the endoplasmic reticulum for viral replication. PMID: 28566381
- We found levels of CHKA to be increased in human HCCs compared to nontumor tissues, and increased expression to be associated with tumor aggressiveness. Overexpression of CHKA in HCC cell lines increased their invasiveness, resistance to EGFR inhibitors, and ability to form metastatic tumors in mice by promoting interaction of EGFR with mechanistic target of rapamycin complex 2. PMID: 28065789
- These findings demonstrate that hCKalpha forms a complex with hepatitis C virus NS5A and that hCKalpha activity enhances the targeting of the complex to the endoplasmic reticulum, where hCKalpha protein, not activity, mediates NS5A binding to NS5B, thereby promoting functional membranous viral replication complex assembly and viral RNA replication. PMID: 27489281
- Study shows increased CHKA expression in pancreatic ductal adenocarcinoma tumors and may be a predictive marker of response to chemotherapy. PMID: 26769123
- These data also support the approach of antitumor strategies that destabilize Chk-alpha protein or downregulate PtdCho in breast cancer treatment. PMID: 26503172
- Downregulation of choline kinase-alpha enhances autophagy in tamoxifen-resistant breast cancer cells. PMID: 26496360
- CHKA can act as an AR chaperone, providing, to our knowledge, the first evidence for kinases as molecular chaperones, making CHKA both a marker of tumor progression and a potential therapeutic target for PCa. PMID: 26657335
- Identify choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma. PMID: 25796169
- choline kinase alpha is inhibited by a near-infrared fluorescent carbocyanine PMID: 25028471
- Increased expression of CHKA is seen in malignant lesions of prostate cancer PMID: 26041862
- Chokalpha possessed oncogenic activity and could be a potential therapeutic target in T-cell lymphoma , as well as other hematological malignancies with interrupted Ras signaling pathways PMID: 25768400
- Downregulation of Chk-alpha with siRNA increased PLD1 expression, and downregulation of PLD1 increased Chk-alpha expression. PMID: 24556997
- there is a role for the ChoKalpha protein in promoting cancer cell survival that is independent of its catalytic activity. PMID: 25522435
- The significance of CHKA overexpression on a TMA. PMID: 25267063
- Our data suggest that choline kinase and its product phosphocholine are required for the normal growth and mineralization of MG-63 cells. PMID: 24583375
- pharmacological inhibition of ChoKalpha induces cancer cell death through a mechanism that involves the activation of exaggerated and persistent ER stress supported by CHOP overproduction. PMID: 24287694
- Chk-alpha expression and the effect of its downregulation in human umbilical vein endothelial cells, is reported. PMID: 23775813
- In EOC that CHKA downregulation significantly decreased the aggressive EOC cell. PMID: 24281000
- CHKA SNPs (rs3794186 and rs11481) are not associated with HCC development; however, rs3794186 may correlate with serum AFP levels in HCC. PMID: 22972156
- High choline kinase A expression is associated with colorectal cancer. PMID: 23762272
- A combination of initial velocity and product inhibition studies, together with the kinetic and structural characterisation of a novel ChoKalpha inhibitor is used to support a mechanism of action for human ChoKalpha. PMID: 23416529
- HK2 and CKA expression may have biologic and prognostic significance in hepatocellular carcinoma, with tumor HK2 expression being a potential independent predictor of survival. PMID: 23071593
- ASAH1 inhibition synergistically sensitizes lung cancer cells resistant to the antiproliferative effect of choline kinase alpha inhibitors. PMID: 22515519
- Data show choline kinase alpha (CHKalpha) expressed in both cytoplasm and nucleus in malignant lesions. PMID: 22038995
- these results strongly implicate a new c-Src-dependent link between CHKA and EGFR, which contributes to the regulation of cell proliferation and tumorigenesis. PMID: 21822308
- kinetic studies revealed that HC-3 is a much more potent inhibitor for ChoKalpha isoforms (alpha1 and alpha2) compared with ChoKbeta. PMID: 20299452
- From our data, we proposed that Choline kinase plays a key role in regulating Akt(ser473) phosphorylation, thereby promoting cell survival and proliferation PMID: 20042122
- ChoKalpha and ChoKbeta isoforms have different physiological roles and implications in human carcinogenesis PMID: 19915674
- Data show that RNA silencing of choline kinase in HeLa cells completely abrogates the high concentration of phosphocholine, which in turn decreases phosphatidylcholine, phosphatidic acid and signaling through the MAPK and PI3K/AKT pathways. PMID: 19855431
- activity regulated by Ras proteins through Ral-GDS and PI-3-kinase; has role in malignant transformation PMID: 11840339
- ChoK overexpression was found in 17% of the samples. ChoK may be related to the development of human breast cancer, suggesting that this finding may suggest a novel antitumoral strategy. PMID: 12082619
- upregulation of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal cancers PMID: 12176020
- ChoK may have a role in carcinogenesis PMID: 16820874
- Analyses showed genotype effects of CHKA genes on spina bifida risk, but did not show evidence of gene-nutrient. PMID: 17184542
- These data suggest that HIF-1 activation of HREs within the putative chk-a promoter region can increase Chk-A expression within hypoxic environments, consequently increasing cellular PC and tCho levels within these environments. PMID: 18172309
- The molecular basis to understand the connection between phospholipids metabolism and cell cycle regulation through choline kinase is reported. PMID: 18296102
- The rates of choline kinase reaction in cell lysates of MDA-MB-231 breast, PC-3 prostate and HeLa cervical cancer cells and in solutions of purified human ChoK, was measured. PMID: 19156696
- ChoKalpha plays a role in the aggressiveness of bladder tumors and constitutes a new approach for bladder cancer treatment. PMID: 19448670
显示更多
收起更多
-
亚细胞定位:Cytoplasm.
-
蛋白家族:Choline/ethanolamine kinase family
-
数据库链接:
HGNC: 1937
OMIM: 118491
KEGG: hsa:1119
STRING: 9606.ENSP00000265689
UniGene: Hs.77221
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-